![]() ![]() ![]() ![]() THE CONTENT MAY NOT BE DISTRIBUTED IN THE PEOPLE ’ S REPUBLIC OF CHINA (“THE PRC”) (EXCEPT IN COMPLIANCE WITH THE APPLICABLE LAWS AND REGULATIONS OF PRC), EXCLUDING SPECIAL ADMINISTRATIVE REGIONS OF HONG KONG AND MACAU Pascal Moura Head of Research (+971) 4 4283 -864 Mairead Smith Equity Focus (+44) 20 754 -71054 CEEMEA Companies TARGET PRICE CHANGE Mediclinic International (Hold, TP GBP502.00) - Tempting to buy after the 34% fall YTD, but actually not that cheap Hold Mediclinic (Hold, TP ZAR93.50) - Tempting to buy after the 34% fall YTD, but actually not that cheap Hold COMPANY UPDATE Gazprom (Hold, TP RUB115.00) - Parent-company investments may grow by 6.3% yoy in 2018 Sibanye-Stillwater (Hold, TP ZAR15.50) - Sibanye-Stillwater finds a neat solution to surface processing SECTOR UPDATE GEMs Oil & Gas Valuation - Monthly update LATAM Companies TARGET PRICE CHANGE GOL S.A. DISCLOSURES AND ANALYST CERTIFICATIONS ARE LOCATED IN APPENDIX 1. Investors should consider this report as only a single factor in making their investment decision. Thus, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. ![]() Deutsche Bank Markets Research Global Periodical CEEMEA & Latam Daybook Date 23 November 2017 Thursday,23 November 2017 _ Deutsche Bank AG/London Deutsche Bank does and seeks to do business with companies covered in its research reports. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |